Company CEO’s Stock Sales Deemed Exempt From Statute’s Holding Requirement
SAN FRANCISCO — A biotechnology company CEO’s sale of 2 million stock options awarded to him by the company’s board of directors less than six months earlier did not violate federal...To view the full article, register now.
Already a subscriber? Click here to view full article